When Will Verona Pharma Plc (NASDAQ:VRNA) Breakeven?

We feel now is a pretty good time to analyse Verona Pharma plc's (NASDAQ:VRNA) business as it appears the company may be on the cusp of a considerable accomplishment. Verona Pharma plc, a clinical s

Simply Wall St09:13 ET

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., April 25, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company") announces that it will report its financial results for the first quarter ended March 31,

GlobeNewswireApr 25 02:00 ET

Express News | Verona Pharma PLC : Btig Raises Target Price to $34 From $31

Moomoo 24/7Apr 24 00:01 ET

European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading

After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index

MT NewswiresApr 22 11:03 ET

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were lower Tuesday morning, declining 0.67% to 1,332.69 on the S&P Europe Select ADR Index. From continental Europe, the gainers were

MT NewswiresApr 16 11:15 ET

Verona Pharma Price Target Raised to $36.00/Share From $31.00 by Piper Sandler

Verona Pharma Price Target Raised to $36.00/Share From $31.00 by Piper Sandler

Dow JonesApr 16 07:59 ET